Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

A precision therapy against cancers driven by KIT/PDGFRA mutations.

Evans EK, Gardino AK, Kim JL, Hodous BL, Shutes A, Davis A, Zhu XJ, Schmidt-Kittler O, Wilson D, Wilson K, DiPietro L, Zhang Y, Brooijmans N, LaBranche TP, Wozniak A, Gebreyohannes YK, Schöffski P, Heinrich MC, DeAngelo DJ, Miller S, Wolf B, Kohl N, Guzi T, Lydon N, Boral A, Lengauer C.

Sci Transl Med. 2017 Nov 1;9(414). pii: eaao1690. doi: 10.1126/scitranslmed.aao1690.

PMID:
29093181
2.

Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model.

LaBranche TP, Bendele AM, Omura BC, Gropp KE, Hurst SI, Bagi CM, Cummings TR, Grantham LE 2nd, Shelton DL, Zorbas MA.

Ann Rheum Dis. 2017 Jan;76(1):295-302. doi: 10.1136/annrheumdis-2015-208913. Epub 2016 Jul 5.

3.

Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich's ataxia.

Nabhan JF, Wood KM, Rao VP, Morin J, Bhamidipaty S, LaBranche TP, Gooch RL, Bozal F, Bulawa CE, Guild BC.

Sci Rep. 2016 Feb 17;6:20019. doi: 10.1038/srep20019.

4.

In vivo imaging implicates CCR2(+) monocytes as regulators of neutrophil recruitment during arthritis.

Wang B, Zinselmeyer BH, Runnels HA, LaBranche TP, Morton PA, Kreisel D, Mack M, Nickerson-Nutter C, Allen PM, Miller MJ.

Cell Immunol. 2012 Jul-Aug;278(1-2):103-12. doi: 10.1016/j.cellimm.2012.07.005. Epub 2012 Aug 4.

5.

JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production.

LaBranche TP, Jesson MI, Radi ZA, Storer CE, Guzova JA, Bonar SL, Thompson JM, Happa FA, Stewart ZS, Zhan Y, Bollinger CS, Bansal PN, Wellen JW, Wilkie DP, Bailey SA, Symanowicz PT, Hegen M, Head RD, Kishore N, Mbalaviele G, Meyer DM.

Arthritis Rheum. 2012 Nov;64(11):3531-42. doi: 10.1002/art.34649.

6.

Enhanced GITR/GITRL interactions augment IL-27 expression and induce IL-10-producing Tr-1 like cells.

Carrier Y, Whitters MJ, Miyashiro JS, LaBranche TP, Ramon HE, Benoit SE, Ryan MS, Keegan SP, Guay H, Douhan J, Collins M, Dunussi-Joannopoulos K, Medley QG.

Eur J Immunol. 2012 Jun;42(6):1393-404. doi: 10.1002/eji.201142162.

7.

Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550).

Ghoreschi K, Jesson MI, Li X, Lee JL, Ghosh S, Alsup JW, Warner JD, Tanaka M, Steward-Tharp SM, Gadina M, Thomas CJ, Minnerly JC, Storer CE, LaBranche TP, Radi ZA, Dowty ME, Head RD, Meyer DM, Kishore N, O'Shea JJ.

J Immunol. 2011 Apr 1;186(7):4234-43. doi: 10.4049/jimmunol.1003668. Epub 2011 Mar 7.

8.

Th17 cells can provide B cell help in autoantibody induced arthritis.

Hickman-Brecks CL, Racz JL, Meyer DM, LaBranche TP, Allen PM.

J Autoimmun. 2011 Feb;36(1):65-75. doi: 10.1016/j.jaut.2010.10.007. Epub 2010 Nov 13.

9.

Characterization of the KRN cell transfer model of rheumatoid arthritis (KRN-CTM), a chronic yet synchronized version of the K/BxN mouse.

LaBranche TP, Hickman-Brecks CL, Meyer DM, Storer CE, Jesson MI, Shevlin KM, Happa FA, Barve RA, Weiss DJ, Minnerly JC, Racz JL, Allen PM.

Am J Pathol. 2010 Sep;177(3):1388-96. doi: 10.2353/ajpath.2010.100195. Epub 2010 Aug 9.

10.

Characterization of bovine neutrophil beta2-adrenergic receptor function.

LaBranche TP, Ehrich MF, Eyre P.

J Vet Pharmacol Ther. 2010 Aug;33(4):323-31. doi: 10.1111/j.1365-2885.2009.01143.x.

PMID:
20646192
11.

Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis.

Peterson JD, Labranche TP, Vasquez KO, Kossodo S, Melton M, Rader R, Listello JT, Abrams MA, Misko TP.

Arthritis Res Ther. 2010;12(3):R105. doi: 10.1186/ar3038. Epub 2010 May 28.

12.

14-deoxyandrographolide as a platelet activating factor antagonist in bovine neutrophils.

Burgos RA, Hidalgo MA, Monsalve J, LaBranche TP, Eyre P, Hancke JL.

Planta Med. 2005 Jul;71(7):604-8.

PMID:
16041644
13.

Platelet-activating factor increases pH(i) in bovine neutrophils through the PI3K-ERK1/2 pathway.

Hidalgo MA, Ojeda F, Eyre P, LaBranche TP, Smith C, Hancke JL, Burgos RA.

Br J Pharmacol. 2004 Jan;141(2):311-21. Epub 2003 Dec 22.

14.

Effect of 14-deoxyandrographolide on calcium-mediated rat uterine smooth muscle contractility.

Burgos RA, Loyola M, Hidalgo MA, Labranche TP, Hancke JL.

Phytother Res. 2003 Nov;17(9):1011-5.

PMID:
14595578
15.

Evaluation of rat neutrophil beta-adrenergic receptors by microphysiometry.

LaBranche TP, Gray LB, Eyre P.

Vet Res Commun. 2001 Feb;25(2):149-52. No abstract available.

PMID:
11243656
16.

Efficacy of fenbendazole in the treatment of experimental Giardia infection in dogs.

Zajac AM, LaBranche TP, Donoghue AR, Chu TC.

Am J Vet Res. 1998 Jan;59(1):61-3.

PMID:
9442246

Supplemental Content

Loading ...
Support Center